These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33560891)

  • 21. Pharmacokinetics, pharmacodynamics, and tolerability of a generic formulation of exenatide: a randomized, open-label, single- and multiple-dose study in healthy Chinese volunteers.
    Shi S; Liu Y; Li Z; Wu J; Zhou X; Zeng F
    Arzneimittelforschung; 2012 Feb; 62(2):75-82. PubMed ID: 22344551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of LBPT and its primary metabolites, as well as tolerability in the first-in-human study.
    Wang H; Liu H; Liu M; Wang W; Zhu L; Huang H; Hu P; Jiang J
    Eur J Pharm Sci; 2017 Mar; 100():87-93. PubMed ID: 28057550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.
    van der Aar E; Desrivot J; Dupont S; Heckmann B; Fieuw A; Stutvoet S; Fagard L; Van de Wal K; Helmer E
    J Clin Pharmacol; 2019 Oct; 59(10):1366-1378. PubMed ID: 31012984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine.
    Vincent J; Harris SI; Foulds G; Dogolo LC; Willavize S; Friedman HL
    Br J Clin Pharmacol; 2000 Nov; 50(5):455-63. PubMed ID: 11069440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
    Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
    Nam JH; Oh M; Kim HJ; Han SK; Kim EJ; Song GS; Kim EY; Shin JG; Ghim JL; Kim HS
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):66-74. PubMed ID: 25034618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
    Hall J; Gillen M; Liu S; Miner JN; Valdez S; Shen Z; Lee C
    Drug Des Devel Ther; 2018; 12():1799-1807. PubMed ID: 29950814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects.
    Qian H; Chen Q; Liang L; Zou Y; Pu H; Xin L; Song R; Li T; Zhu H; Wang Y; Tian G; Shen J; Jiang H; Yu C; Wang Z; Jia J
    Drug Des Devel Ther; 2021; 15():2947-2959. PubMed ID: 34262260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers.
    Barde PJ; Viswanadha S; Veeraraghavan S; Vakkalanka SV; Nair A
    J Clin Pharm Ther; 2021 Jun; 46(3):677-687. PubMed ID: 33314326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals.
    Hu Y; Zhang H; Wu M; Liu J; Li X; Zhu X; Li C; Chen H; Liu C; Niu J; Ding Y
    Expert Opin Investig Drugs; 2021 Mar; 30(3):263-269. PubMed ID: 33405993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension.
    Dingemanse J; Otasevic P; Shakeri-Nejad K; Klainman E; Putnikovic B; Kracker H; Mueller MS; Zimlichman R
    J Hum Hypertens; 2015 Apr; 29(4):229-35. PubMed ID: 25231512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker.
    Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
    Liu X; Xue L; Zhang H; Xu Q; Zhang S; Ma S; Ding X; Liu L; Dong J; Qian L; Xia W; Jiang K; Huang C; Miao L
    Clin Drug Investig; 2020 Jun; 40(6):555-566. PubMed ID: 32277364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
    Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects.
    Marino MR; Langenbacher K; Ford NF; Uderman HD
    J Clin Pharmacol; 1998 Mar; 38(3):246-55. PubMed ID: 9549663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.
    Frost C; Wang J; Nepal S; Schuster A; Barrett YC; Mosqueda-Garcia R; Reeves RA; LaCreta F
    Br J Clin Pharmacol; 2013 Feb; 75(2):476-87. PubMed ID: 22759198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
    Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J; Abrahamsson B; Grind M; Nyberg G; Olofsson B
    Eur J Clin Pharmacol; 1997; 52(6):471-7. PubMed ID: 9342583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects.
    Wang S; Chen G; Merlo Pich E; Affinito J; Cwik M; Faessel H
    Br J Clin Pharmacol; 2021 Nov; 87(11):4354-4365. PubMed ID: 33837574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.